For millions of Americans, surviving an illness can create a second crisis after the medical emergency itself has passed: medical debt. A cancer diagnosis, emergency surgery, complicated pregnancy, chronic illness or unexpected hospitalisation can leave families facing bills they cannot realistically afford, even when they have health insurance. Those debts can follow patients for years, affecting household budgets, savings, access to credit and decisions about whether to seek future medical care. Against this backdrop, a U.S. nonprofit called Undue Medical Debt, formerly known as RIP Medical Debt, has developed an unusual model: it raises philanthropic funding, acquires large portfolios of qualifying medical debt from hospitals, health systems and debt markets at steep discounts, and then abolishes the debt rather than collecting it. By the end of 2025, the organisation reported that it had erased $25 billion in medical debt for more than 15 million people and families across all 50 U.S. states. More recent audited financial statements, published in June 2026, report that since its founding the organisation had abolished more than $27.3 billion in medical debt affecting approximately 17.9 million people, meaning the viral claim of helping more than 15 million Americans is broadly accurate, although describing the programme simply as “paying off hospital bills” misses the innovative financial mechanism that makes its scale possible.
The organisation’s story began in 2014 with a remarkable insight into how the American debt market works. Medical bills that patients cannot pay are sometimes retained by healthcare providers for collection or sold in portfolios at a fraction of their original face value because creditors recognise that recovering the full amount is unlikely. Traditional debt buyers purchase these portfolios cheaply and then attempt to collect enough from patients to make a profit. The founders of what became Undue Medical Debt understood that the same market mechanism could be reversed. Instead of buying distressed medical debt to pursue patients, a nonprofit could use donated money to acquire qualifying portfolios and erase them permanently. Undue says that, on average, $1 donated can eliminate about $100 of medical debt, because the organisation acquires large bundled portfolios at substantial discounts rather than paying every patient’s original hospital bill dollar for dollar. Once qualifying debt is acquired, collection activity stops and the patient receives notice that the debt has been abolished.
That distinction is central to understanding why the model can operate at such extraordinary scale. If a philanthropist donated $1 million and the organisation simply paid hospitals $1 million against individual patients’ current bills, the maximum nominal relief would be approximately $1 million. But distressed debt may be valued at only a small percentage of its original balance because the probability of full repayment has declined. Acquiring those portfolios wholesale allows philanthropic capital to extinguish a much larger face value of debt. The model effectively takes an instrument created by the debt-collection industry and turns it toward social relief. It is a striking example of financial engineering being used for public benefit: the organisation does not manufacture new money; it exploits the difference between what distressed debt is nominally owed and what the market believes that debt is realistically worth.
Undue Medical Debt does not allow individuals simply to apply online and request that any medical bill be cancelled. Instead, it acquires portfolios from participating hospitals, health systems and other debt holders and identifies qualifying accounts within those portfolios. According to the organisation, its traditional eligibility criteria prioritise people whose household income is at or below four times the federal poverty level or whose medical debt represents 5% or more of annual household income. Eligible debt is then abolished without requiring recipients to negotiate settlements or make partial payments. This automatic approach is important because people overwhelmed by medical bills may not know that assistance exists, may struggle with complex hospital financial-assistance systems or may avoid engaging with debt collectors altogether.
The scale of Undue Medical Debt’s growth has been extraordinary. By 2019, roughly five years after its founding, it had reached the milestone of $1 billion in medical debt abolished for approximately 500,000 families. By April 2023, reporting showed more than $8.5 billion erased for 5.4 million Americans. By December 2024, the organisation had relieved nearly $15 billion for more than nine million people. In June 2025, it announced that cumulative relief had reached $20.3 billion for 13 million people. Its 2025 impact report subsequently recorded the $25 billion and 15 million milestone, while audited 2025 financial statements published in 2026 put cumulative relief above $27.3 billion affecting approximately 17.9 million people. The rapid expansion demonstrates how philanthropic capital, large-scale debt acquisition and partnerships with governments and healthcare institutions can produce effects far larger than conventional one-patient-at-a-time charitable assistance.
The organisation’s rise also reveals the enormous scale of the underlying U.S. medical debt crisis. Healthcare in the United States combines private insurance, employer-sponsored coverage, government programmes and direct patient payments in one of the world’s most complex health-financing systems. Insurance does not necessarily protect households from substantial bills because patients may face deductibles, copayments, coinsurance, uncovered services or treatment received outside insurance networks. People without adequate insurance face even greater exposure. Estimates cited by Undue and major reporting put Americans’ collective medical debt at roughly $220 billion, with lower-income households, people with disabilities, rural residents, uninsured people and some racial and ethnic minority communities disproportionately affected.
Medical debt differs fundamentally from many other forms of consumer borrowing because it is frequently involuntary. People generally choose whether to finance a car, use a credit card for discretionary purchases or take a mortgage based on expected income and repayment capacity. A person experiencing a heart attack does not comparison-shop for an affordable emergency before seeking treatment. Parents do not schedule a child’s accident according to their household cash flow. Cancer does not ask whether a patient has sufficient savings before diagnosis. Healthcare expenses can therefore generate debt precisely when families are most vulnerable—when illness may simultaneously reduce income, increase caregiving responsibilities and create new transport, medication and living costs.
This creates what might be called a double burden of disease: the biological cost of becoming sick and the financial cost of receiving treatment. A person may recover medically but remain economically damaged for years. Families can deplete emergency savings, borrow from relatives, use high-interest credit, postpone rent or mortgage payments, reduce spending on food and education or delay other healthcare. Medical debt can therefore transform a temporary health emergency into a prolonged household financial crisis. Undue’s model attacks the second part of that crisis by removing qualifying legacy debt, allowing recipients to redirect money and attention toward current needs rather than bills they may have little realistic ability to repay.
The psychological dimension is equally significant. Debt is not merely an accounting entry. It can represent years of collection notices, telephone calls, uncertainty and fear about household finances. Undue has highlighted research linking debt with increased psychological distress and greater likelihood of anxiety or depression. For a family already dealing with illness, recovery or bereavement, repeated reminders of unpaid medical bills can prolong the emotional consequences of a health crisis. Eliminating debt therefore has a value that cannot be measured solely by the nominal dollar amount erased: it can provide financial and psychological breathing room.
There is also an important connection between medical debt and financial inclusion. A health emergency can affect much more than a person’s relationship with a hospital. When medical debt appears on credit reports, it can influence access to mortgages, credit cards and other financial products, although credit-reporting rules around medical debt have changed significantly in recent years and remain politically contested. The three major U.S. credit bureaus stopped including certain smaller medical debts and paid medical collections under reforms introduced earlier in the decade, while some states enacted stronger protections. Policy around whether and how medical debt can be reported remains contested, illustrating how healthcare affordability can spill directly into participation in the wider financial system.
The deeper economic problem is that medical debt can create a cycle in which poor health produces financial insecurity and financial insecurity contributes to poorer health. Someone worried about accumulating another bill may postpone a doctor’s visit, diagnostic test or prescription. Delayed care can allow manageable conditions to worsen until they require more expensive treatment. That creates larger bills, greater income disruption and potentially more debt. Breaking this cycle requires more than forgiving old balances; it requires healthcare financing that makes early and preventive care affordable before debt develops.
Undue Medical Debt itself explicitly acknowledges this limitation. The organisation describes debt relief as immediate assistance rather than a complete solution to the structural causes of medical debt and has expanded its work into policy advocacy intended to prevent new debts from accumulating. Its stated objective is ultimately paradoxical for a nonprofit: to help create conditions in which its debt-relief service is no longer necessary. That means addressing hospital financial-assistance practices, consumer protections, insurance coverage, affordability and the systems that determine how patients are billed and pursued for payment.
This distinction matters because erasing medical debt does not make healthcare itself cheaper. If a hospital provides a service costing thousands of dollars and the patient cannot pay, cancelling the debt relieves the patient but does not eliminate the economic cost of delivering care. Someone ultimately bears that cost through hospital finances, insurance premiums, government programmes, philanthropy or cross-subsidisation. Debt relief therefore addresses the consequences of unaffordable care rather than automatically fixing the mechanisms producing unaffordable bills. A sustainable solution must work upstream by improving insurance coverage, pricing transparency, preventive care, financial assistance and the relationship between healthcare costs and household incomes.
One of the most significant developments in the model has been the emergence of government partnerships. State and local governments have increasingly worked with Undue Medical Debt or adopted related strategies to eliminate qualifying residents’ medical debt. Some municipalities used federal American Rescue Plan funding to purchase and abolish debt portfolios, effectively multiplying relatively modest public allocations into much larger nominal debt relief. The approach illustrates how governments can use philanthropic financial mechanisms as part of social policy rather than building entirely new administrative systems.
North Carolina has gone even further with a structurally different approach. In 2025, state officials announced that more than $6.5 billion in medical debt was being eliminated for over 2.5 million residents through an initiative linking enhanced Medicaid-related hospital funding with requirements to forgive qualifying debt and implement policies intended to reduce future medical indebtedness. Participating hospitals agreed to measures including eliminating historical debt for eligible populations and improving charity-care practices. The programme attracted national attention because it did not merely purchase old debt; it used the government’s purchasing and reimbursement power to change hospital behaviour upstream.
This represents an important evolution in the medical-debt movement: from charitable relief toward systems redesign. Buying and abolishing distressed debt can provide immediate benefits to millions of people, but preventing the next generation of medical debt requires changing how patients enter the system, how financial assistance is determined, when hospitals bill, what collection practices are permitted and how public insurance incentives are structured. North Carolina’s model demonstrates how government financing can potentially reward healthcare institutions for both eliminating legacy debt and preventing new unaffordable balances.
Philanthropy has nevertheless been essential to scaling Undue’s work. Billionaire philanthropist MacKenzie Scott, for example, made three major gifts to the organisation totalling $130 million between 2020 and 2024, including a $50 million contribution announced in December 2024. Because of the organisation’s discounted debt-acquisition model, large unrestricted donations can potentially unlock relief many times greater than their face value. Scott’s support also provided something equally important for a growing nonprofit: the ability to plan beyond short fundraising cycles and invest in institutional capacity, partnerships and policy work.
The story therefore offers a fascinating case study in strategic philanthropy. Traditional charity often transfers resources directly from donors to beneficiaries: one dollar donated becomes approximately one dollar of assistance, minus operating costs. Undue’s model uses market pricing to create leverage. A donated dollar can extinguish a much larger nominal liability because distressed debt trades far below face value. This does not mean $1 magically creates $100 of new economic value, the market had already discounted the probability that much of the debt would ever be collected, but it does mean philanthropy can remove a $100 legal obligation from a struggling patient at a cost far below $100. The difference between face value and market value becomes a tool for social impact.
That idea has implications far beyond American healthcare. Around the world, households face debt related to medical treatment, school fees, agriculture, informal lending and small-business failure. Not every debt market has the legal structure or pricing dynamics that make the U.S. medical-debt model transferable, but the underlying principle deserves attention: can financial mechanisms originally designed to maximise collection or profit be redesigned to maximise social outcomes? Impact investing, blended finance, guarantee funds, debt restructuring and results-based financing all operate on variations of this broader idea, using financial architecture itself as a development tool
For Africa, however, the lesson should not be to copy the American medical-debt system and then build charities to repair its consequences. In many African countries, a large share of healthcare expenditure is still paid directly out of pocket, and families can experience catastrophic financial pressure when serious illness strikes. The stronger lesson is to prevent medical debt before it becomes entrenched by expanding universal health coverage, affordable insurance, community-based financing, digital health access and early intervention.
A household earning irregular income in Uganda, Kenya, Zambia or Malawi may be one hospital admission away from selling livestock, withdrawing children from school, borrowing at high interest or exhausting business capital. For informal-sector workers, the risk is particularly severe because income may stop immediately when illness prevents them from working. Health financing therefore cannot be separated from financial inclusion. A person may have a mobile-money wallet, bank account or small business and still be financially vulnerable if one medical emergency can wipe out years of accumulated progress.
This is where digital health and inclusive finance can converge. Affordable microinsurance, mobile-based health subscriptions, telemedicine, digital savings products, emergency health funds and interoperable payment systems can reduce the probability that a relatively manageable health problem becomes a catastrophic expense. Telemedicine can lower the cost of initial consultations and encourage earlier diagnosis. Digital payments can make small, regular health contributions easier for informal workers. Data can support more appropriate risk pooling. Mobile platforms can connect patients to financial assistance before bills become unmanageable. The objective should be to create a continuum in which healthcare access and financial protection reinforce each other.
The Undue Medical Debt story also raises a fundamental question about how societies define financial inclusion. Opening a bank account is not enough if illness can immediately destroy a household balance sheet. Giving someone access to credit is not necessarily empowering if they must borrow to survive a medical emergency. True financial resilience means households can absorb shocks without falling permanently into poverty. Health protection must therefore be treated as part of the financial inclusion architecture alongside savings, payments, insurance and responsible credit.
There is an equally important lesson for hospitals. Healthcare providers understandably need revenue to pay staff, purchase medicines, maintain equipment and remain operational. But aggressive collection from patients who demonstrably cannot pay may recover relatively little while creating enormous social harm. Better financial-assistance screening, transparent pricing, realistic payment plans and automatic identification of eligible low-income patients can reduce unnecessary debt before it reaches collection. The most efficient medical debt may be the debt that is never created because the patient was correctly identified for assistance at the beginning.
Technology could make that process significantly more intelligent. With appropriate privacy safeguards, healthcare systems can use digital eligibility systems to identify patients who qualify for subsidies or charity care, automatically connect them to available programmes and provide transparent estimates before non-emergency treatment. Artificial intelligence could assist with administrative triage, while interoperable health and financial systems could reduce paperwork. But automation must be designed carefully: algorithms used to determine affordability or eligibility can reproduce inequality if built on biased or incomplete data. Digital transformation should make compassionate policies easier to deliver, not make exclusion more efficient.
The scale reached by Undue Medical Debt is impressive, but perhaps the most important fact is that the organisation itself does not present tens of billions of dollars in cancelled debt as evidence that the healthcare financing problem has been solved. The opposite is true. The need for a charity capable of eliminating billions in unpaid medical bills demonstrates how deeply medical and financial vulnerability remain intertwined in the United States. By June 2025, the nonprofit had erased $20.3 billion for 13 million people; by the end of that year, its impact report recorded $25 billion for more than 15 million; and its latest audited statements report more than $27.3 billion affecting approximately 17.9 million people since 2014. The numbers are extraordinary, but they are also a measure of how many households entered the healthcare system without sufficient financial protection.
The viral claim that a U.S. nonprofit has helped more than 15 million Americans by paying off unpaid hospital bills therefore captures the emotional core of the story but oversimplifies the mechanics. Undue Medical Debt generally does not pay each patient’s original hospital balance at full value. It uses donated funds and public partnerships to acquire qualifying medical debt in bulk at substantial discounts and then abolish the legal obligation, ending collection activity on the acquired debt. That difference is precisely what makes the model so powerful: it transforms the economics of distressed debt into a mechanism for relief.
Ultimately, the story is about much more than cancelled bills. It is about what happens when healthcare and finance collide at the worst possible moment in a person’s life. People do not choose cancer, heart attacks, premature births or accidents, yet the financial consequences of receiving treatment can shape their lives long after the medical crisis ends. Undue Medical Debt has demonstrated that financial innovation can erase part of that burden at extraordinary scale. The next challenge is harder: building healthcare systems in which families do not accumulate unaffordable medical debt in the first place.
Because a society should not have to choose between saving a life and saving a livelihood. And the ultimate measure of healthcare should not simply be whether a patient leaves the hospital alive and healthier. It should also ask whether they can leave without carrying the financial consequences of their illness for the rest of their life.
